NeuShen Therapeutics Celebrates New Headquarters in Shanghai Zhangjiang Twin Towers
Shanghai, China and Boston, MA., – July 7, 2026 – On July 3, 2026, NeuShen Therapeutics ("NeuShen" or the "Company") celebrated the opening of its new headquarters in Shanghai Zhangjiang Twin Towers, marking a significant milestone in the Company's continued growth. The ceremony, themed "New Stage, New Dream," brought together employees, government officials, investors, and industry partners to witness this important occasion.
Dr. Joan Huaqiong Shen, Founder and CEO of NeuShen Therapeutics, opened the ceremony by expressing her gratitude to employees, investors, partners, and supporters for their trust and commitment. Reflecting on the Company's journey from its founding to its current achievements, she highlighted the global clinical progress of NeuShen's differentiated CNS pipeline and reaffirmed the Company's vision to advance innovation in CNS therapeutics. Dr. Shen noted that the new headquarters represents not only an upgraded workspace, but also the launch of NeuShen's next stage of growth and innovation.
Various guests also delivered congratulatory remarks, recognizing NeuShen's achievements and expressing confidence in its long-term vision. Speakers described the new headquarters as both an important milestone for the Company and a testament to Shanghai's dynamic biopharmaceutical innovation ecosystem. They also reaffirmed their commitment to deepening collaboration with NeuShen to accelerate the development of innovative therapies for brain disease patients worldwide.
The celebration concluded with a ribbon-cutting ceremony led by Company executives and distinguished guests. Guests then toured the new office space and continued discussions during a luncheon.
The opening of the Company's new headquarters marks the beginning of an exciting new chapter for NeuShen Therapeutics. Building on its foundation of scientific excellence and innovation, NeuShen remains committed to advancing its clinical pipeline and developing transformative therapies for patients with CNS disorders around the world.







About NeuShen Therapeutics
NeuShen Therapeutics is a clinical-stage global biotechnology company focused on developing innovative therapies for neurological and psychiatric disorders. With R&D centers in Shanghai and Boston, the Company brings together an international team of R&D experts and is advised by a group seasoned leaders in academia and industry. NeuShen Therapeutics has established a globally competitive CNS drug pipeline including multiple programs with first- or best-in-class potentials, and its lead assets have advanced into Phase 2 clinical development.
Related News